Nonbacterial Thrombotic Endocarditis With Underlying Ovarian Carcinoma Resolving With Oncologic Treatment
- 26 September 2023
- journal article
- research article
- Published by Taylor & Francis in Future Cardiology
- Vol. 19 (11) , 523-528
Abstract
The treatment of nonbacterial thrombotic endocarditis consists of anticoagulation, surgical consideration and treatment of the underlying disease, most commonly lupus or malignancy. We report a cas...Keywords
This publication has 9 references indexed in Scilit:
- Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With CancerJAMA, 2023
- Lung Cancer as a Leading Cause among Paraneoplastic Non-Bacterial Thrombotic Endocarditis: A Meta-Analysis of Individual Patients’ DataCancers, 2023
- Venous thromboembolism in cancer patients: ESMO Clinical Practice GuidelineAnnals of Oncology, 2023
- A Contemporary 20-Year Cleveland Clinic Experience of Nonbacterial Thrombotic Endocarditis: Etiology, Echocardiographic Imaging, Management, and OutcomesThe American Journal of Medicine, 2021
- American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancerBlood Advances, 2021
- Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysisPLOS ONE, 2019
- Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysisThrombosis Research, 2019
- Nonbacterial Thrombotic Endocarditis (Marantic Endocarditis) in Cancer PatientsCardiovascular & Hematological Disorders-Drug Targets, 2010
- Nonbacterial Thrombotic Endocarditis in Cancer Patients: Pathogenesis, Diagnosis, and TreatmentThe Oncologist, 2007